Deep Candida infection in children receiving allogeneic bone marrow transplants: Incidence, risk factors and diagnosis

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 1043-1049

  Klingspor, L ^a   Stintzing, G ^a   Fasth, A ^b   Tollemar, J ^c  

^a DANDERYD HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BMT; Candida; Children

Indexed keywords

ANTIFUNGAL AGENT; GLYCOPROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY TITER; ARTICLE; AUTOPSY; CANDIDIASIS; CHILD; DIAGNOSTIC VALUE; DONOR; EARLY DIAGNOSIS; FEMALE; FUNGUS CULTURE; HERPES SIMPLEX VIRUS; HLA MATCHING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SERODIAGNOSIS;

ADOLESCENT; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; BONE MARROW TRANSPLANTATION; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUCONAZOLE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030037439     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tollemar J, Ringdén O, Boström L et al. Variables predicting deep fungal infections in bone marrow transplant recipients. Bone Marrow Transplant 1989; 4: 635-641.
2. Tollemar J, Holmberg K, Ringdén O, Lönnqvist B. Surveillance tests for the diagnosis of invasive fungal infections in bone marrow transplant recipients. Scand J Infect Dis 1989; 21: 205-212.
3. Klingspor L, Eberhard T, Stintzing G, Tollemar J. Antibody response to Candida and its use in clinical practice. Mycoses 1994; 37: 199-204.
4. Ringdén O, Klaesson S, Sundberg B et al. Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical silbings. Bone Marrow Transplant 1992; 9: 19-25.
5. Ringdén O, Groth CG, Erikson A et al. Ten years' experience of bone marrow transplantation for Gauchers disease. Transplantation 1995; 59: 864-870.
6. Ringdén O, Bolme P, Lönnqvist B et al. Bone marrow transplantation in children. Clin Transplantation 1989; 3: 12-18.
7. Tollemar J, Ringdén O, Andersen S et al. Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients. Transplant Proc 1993; 25: 1495-1497.
8. Eberhard T, Möllby R. An enzyme-linked immunosorbant assay (ELISA) for the detection of serum IgA against Candida albicans mannan. Serodiagn Immunother Infect Dis 1993; 5: 171-176.
9. Müller HL, Holtmannspötter H. Vergleichende Titerbestimmungen mit dem Candida-Hämagglutinationstest und dem Candida-Immunofluoreszenztest. Mykosen 1975; 18: 91-96.
10. Axelson NH (ed.). Handbook of immunoprecipitation-in-gel techniques. Scand J Immunol 1983; 17 (Suppl. 10): 97-124.
11. Wadström T. Immunoelectro-osmophoresis or counter-electrophoresis. Scand J Immunol 1985; 17 (Suppl. 10): 97-102.
12. Syverson RE, Buckley HR, Gibian JR. Increasing the predictive value positive of the precipitive test for the diagnosis of deepseated candidiasis. Am J Clin Pathol 1978; 70: 826-831.
13. Gentry LO, Wilkinson ID, Lea AS, Price MF. Latex agglutination test for detection of Candida antigen in patients with diseeminated disease. Eur J Clin Microbiol 1983; 2: 122-128.
14. Siegel S. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill: New York, 1956.
15. Breslow NE, Day NE. Statistical Methods in Cancer Research. The Analysis of Case-control Studies: Odds Ratio. International Agency for Research on Cancer: Lyons: 1980, pp 70-80.
16. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretations of diagnostic tests and procedures. Ann Intern Med 1981; 94: 553-600.
17. Hay RJ. Dimorphism and candidosis: clinical and therapeutic implications. Diagnosis and treatment of mycosis. In: Van den Bossche H, Odds FC, Kerridge D (eds). Dimorphic Fungi in Biology and Medicine. Plenum Press: New York, 1993, pp 373-379.
18. Dupont B. Clinical manifestations and management of candidosis in the compromised patient. In: Warnock DW, Richardson MD (eds). Fungal Infection in the Compromised Patient, 2nd edn. Wiley: Chichester, 1991, pp 56-81.
19. Kay HEM, Watson JG, Jameson B, Morgenstern GR, Powles RL. Infections after bone marrow transplantation using cyclosporin. Transplantation 1983; 36: 491-495.
20. Meunier-Carpentier F. Chemoprophylaxis of fungal infections. Am J Med 1984; 76: 652-656.
21. Young LS. An overview of infection in bone marrow transplant recipients. Clin Hematol 1984; 13: 661-678.
22. Klingspor L, Stintzing G, Tollemar J. Deep Candida infection in child liver transplant recipients: serological diagnosis and incidence. Acta Paediatr 1995; 84: 424-428.
23. Verfaille C, Wiesdorf D, Haake R et al. Candida infections in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 177-184.
24. Paulin T, Ringdén O, Nilsson B et al. Variables predicting bacterial and fungal infections after allogeneic marrow engraftment. Transplantation 1987; 43: 393-398.
25. Goodrich JM, Reed EC, Mori M et al. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 1991; 164: 731-740.
26. Boström L, Ringdén O, Sundberg B et al. Pretransplant and herpes virus serology and acute graft-versus-host disease. Transplantation 1988; 46: 548-552.